Síndrome de Steele Richardson-Olszewski: Revisión de tema

Juan Sebastián  Theran León; Luis Andrés   Dulcey Sarmiento; María Fernanda   Forero Trillos; Miguel Fernando   García Brilla; Eduardo Andrés   Gutiérrez Gómez; Kimberley  Ordoñez Llanes; Andrés Mauricio   Sánchez Herrera

doi:10.37811/cl_rcm.v6i3.2285

Juan Sebastián Theran León Residente medicina familiar UDES-Bucaramanga, Colombia https://orcid.org/0000-0002-4742-0403
Luis Andrés Dulcey Sarmiento Especialista en medicina interna. Universidad de los Andes, Bucaramanga https://orcid.org/0000-0001-9306-0413
María Fernanda Forero Trillos Medica general de la universidad autónoma de Bucaramanga https://orcid.org/0000-0002-9905-7992
Miguel Fernando García Brilla Residente medicina familiar UDES-Bucaramanga, Colombia https://orcid.org/0000-0001-8131-069X
Eduardo Andrés Gutiérrez Gómez Medico general de la universidad de Santander https://orcid.org/0000-0002-5535-0388
Kimberley Ordoñez Llanes Medica General de la Universidad Autónoma de Bucaramanga https://orcid.org/0000-0002-9905-7992
Andrés Mauricio Sánchez Herrera Residente medicina familiar UDES-Bucaramanga, Colombia https://orcid.org/0000-0002-7084-3201

DOI: https://doi.org/10.37811/cl_rcm.v6i3.2285

Palabras clave: parálisis, espranuclear, progresiva, síndrome, Steele-Richardson-Olszewski, síndrome de Parkinson acinético-rígido

Resumen

Los síndromes de Parkinson atípicos como la parálisis supranuclear progresiva (PSP), también conocida como síndrome de Steele-Richardson-Olszewski son síndromes neurológicos atípicos de presentación tardía, con 7 variantes clínicas con supervivencia muy baja tras el diagnóstico, requiere de 1 manejo multidisciplinario para lograr los mejores objetivos, así como la participación activa del entorno familiar.

Descargas

La descarga de datos todavía no está disponible.

Citas

Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM, (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. Journal of Neurology, Neurosurgery, and Psychiatry 58 (2), 167-73 https://pubmed.ncbi.nlm.nih.gov/7876846/

Gold M et al. (2012) Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. Neuropsychiatric Disease and Treatment 8: 85-93 https://pubmed.ncbi.nlm.nih.gov/22347799/

Morris HR, Wood NW, Lees AJ (1999) Classic diseases revisited: Progressive supranuclear palsy (Steele-Richardson-Olszewski disease). Postgrad Med J 75 (888), 579–584. https://pmj.bmj.com/content/postgradmedj/75/888/579.full.pdf

Maher ER, Smith EM, Lees AJ (1985) Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Journal of Neurology, Neurosurgery, and Psychiatry 48 (12), 1234-1239. https://pubmed.ncbi.nlm.nih.gov/4086998/

Barclay CL & Lang AE (1997) Dystonia in progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry 62 (4), 352–6. https://jnnp.bmj.com/content/62/4/352.long

Neophytides A et al. (1982) The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. Journal of Neurology, Neurosurgery, and Psychiatry 45 (3), 261-3 https://pubmed.ncbi.nlm.nih.gov/7086448/

Tawana K & Ramsden DB (2001) Progressive supranuclear palsy. J Clin Pathol: Mol Pathol 54 (6), 427-34 https://pubmed.ncbi.nlm.nih.gov/11724919/

Williams DR & Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. The Lancet Neurology. 8 (3), 270–9. http://linkinghub.elsevier.com/ retrieve/pii/S1474442209700420.

Golbe LI (2018) A Clinician’s guide to Progressive Supranuclear Palsy 1th ed. New Jersey, USA: Rutgers University Press

Ali F & Josephs K. (2018) The diagnosis of progressive supranuclear palsy: current opinions and challenges. Expert Review of Neurotherapeutics 18 (7), 603-616 https://pubmed.ncbi.nlm.nih.gov/29902389/

Litvan I et al. (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47 (1), 1-9 https://pubmed.ncbi.nlm.nih.gov/8710059/

Armstrong MJ (2018) Progressive Supranuclear Palsy: an Update. Current Neurology and Neuroscience Reports 18 (3), 12 https://pubmed.ncbi.nlm.nih.gov/29455271/

Höglinger GU et al. (2017) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders 32 (6), 853–864 https://pubmed.ncbi.nlm.nih.gov/28467028/

Respondek G et al. (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Movement Disorders 29 (14), 1758-66 https://pubmed.ncbi.nlm.nih.gov/25370486/

McFarland NR (2016) Diagnostic Approach to Atypical Parkinsonian Syndromes. Continuum (Minneap Minn) 22 (4 Movement Disorders), 1117–1142 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567217/

Intiso D, Bartolo M, Santamato A, Di Rienzo F (2018) The Role of Rehabilitation in Patients With Progressive Supranuclear Palsy: A Narrative Review. PM & R 10 (6), 636-645. https://onlinelibrary.wiley.com/doi/abs/10.1016/j.pmrj.2017.12.011

Boxer AL et al (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. The Lancet Neurology 16 (7), 552-563 https://pubmed.ncbi.nlm.nih.gov/28653647/

Agarwal S & Gilbert R (2022) Progressive Supranuclear Palsy, Treasure Island (FL): StatPearls Publishing https://pubmed.ncbi.nlm.nih.gov/30252354/

Martín AL (2017) Plan de cuidados en paciente con parálisis supranuclear progresiva en fase avanzada, Revista Reduca 9 (1) http://revistareduca.es/index.php/reduca-enfermeria/article/view/1931

Ling H (2016) Clinical Approach to Progressive Supranuclear Palsy. Journal of Movement Disorders 9 (1), 3–13 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734991/

Síndrome de Steele Richardson-Olszewski: Revisión de tema

Resumen

Descargas

Citas

Artículos más leídos del mismo autor/a

Contacto principal:

Institución coeditora:

Institución aliada: